These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20195930)

  • 1. Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.
    Geeraedts F; Saluja V; ter Veer W; Amorij JP; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
    AAPS J; 2010 Jun; 12(2):215-22. PubMed ID: 20195930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants.
    Murugappan S; Patil HP; Kanojia G; ter Veer W; Meijerhof T; Frijlink HW; Huckriede A; Hinrichs WL
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):716-25. PubMed ID: 23933147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation.
    Flood A; Estrada M; McAdams D; Ji Y; Chen D
    PLoS One; 2016; 11(11):e0164692. PubMed ID: 27851765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization.
    Audouy SA; van der Schaaf G; Hinrichs WL; Frijlink HW; Wilschut J; Huckriede A
    Vaccine; 2011 Jun; 29(26):4345-52. PubMed ID: 21514345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of stable influenza vaccine powder formulations: challenges and possibilities.
    Amorij JP; Huckriede A; Wilschut J; Frijlink HW; Hinrichs WL
    Pharm Res; 2008 Jun; 25(6):1256-73. PubMed ID: 18338241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up.
    Zhu C; Shoji Y; McCray S; Burke M; Hartman CE; Chichester JA; Breit J; Yusibov V; Chen D; Lal M
    Pharm Res; 2014 Nov; 31(11):3006-18. PubMed ID: 24858396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates.
    Scherließ R; Ajmera A; Dennis M; Carroll MW; Altrichter J; Silman NJ; Scholz M; Kemter K; Marriott AC
    Vaccine; 2014 Apr; 32(19):2231-40. PubMed ID: 24631078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Optimization of a Temperature-Stable Dry Powder BCG Vaccine.
    Price DN; Kunda NK; Ellis R; Muttil P
    Pharm Res; 2019 Dec; 37(1):11. PubMed ID: 31873825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using different adjuvant formulations.
    Miyaki C; Quintilio W; Miyaji EN; Botosso VF; Kubrusly FS; Santos FL; Iourtov D; Higashi HG; Raw I
    Vaccine; 2010 Mar; 28(13):2505-9. PubMed ID: 20123051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars.
    Tonnis WF; Amorij JP; Vreeman MA; Frijlink HW; Kersten GF; Hinrichs WL
    Eur J Pharm Sci; 2014 May; 55():36-45. PubMed ID: 24468629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus.
    Peeters B; Tonnis WF; Murugappan S; Rottier P; Koch G; Frijlink HW; Huckriede A; Hinrichs WL
    Vaccine; 2014 Nov; 32(48):6445-50. PubMed ID: 25285885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.
    Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
    Pharm Res; 2011 Jan; 28(1):135-44. PubMed ID: 20387097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.
    Saluja V; Amorij JP; Kapteyn JC; de Boer AH; Frijlink HW; Hinrichs WL
    J Control Release; 2010 Jun; 144(2):127-33. PubMed ID: 20219608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
    Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of Live Attenuated Influenza Vaccines by Freeze Drying, Spray Drying, and Foam Drying.
    Lovalenti PM; Anderl J; Yee L; Nguyen V; Ghavami B; Ohtake S; Saxena A; Voss T; Truong-Le V
    Pharm Res; 2016 May; 33(5):1144-60. PubMed ID: 26818839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of neuraminidase in inactivated influenza vaccines.
    Sultana I; Yang K; Getie-Kebtie M; Couzens L; Markoff L; Alterman M; Eichelberger MC
    Vaccine; 2014 Apr; 32(19):2225-30. PubMed ID: 24613525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration.
    Patil HP; Murugappan S; de Vries-Idema J; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
    Eur J Pharm Biopharm; 2015 Jun; 93():231-41. PubMed ID: 25896446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.
    Geeraedts F; Goutagny N; Hornung V; Severa M; de Haan A; Pool J; Wilschut J; Fitzgerald KA; Huckriede A
    PLoS Pathog; 2008 Aug; 4(8):e1000138. PubMed ID: 18769719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive inhalation of dry powder influenza vaccine formulations completely protects chickens against H5N1 lethal viral challenge.
    Tomar J; Biel C; de Haan CAM; Rottier PJM; Petrovsky N; Frijlink HW; Huckriede A; Hinrichs WLJ; Peeters B
    Eur J Pharm Biopharm; 2018 Dec; 133():85-95. PubMed ID: 30312742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of dry powders of vaccines containing MF59 or AddaVax by Thin-Film Freeze-Drying: Towards a dry powder universal flu vaccine.
    AboulFotouh K; Uno N; Xu H; Moon C; Sahakijpijarn S; Christensen DJ; Davenport GJ; Cano C; Ross TM; Williams Iii RO; Cui Z
    Int J Pharm; 2022 Aug; 624():122021. PubMed ID: 35842082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.